Aktuelle klinische Studien
Studien bei Nierenzellkarzinom
| Projekt | Projektleiter |
|---|---|
| VEG113387 PROTECT A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of pazopanib as adjuvant therapy for subjects with localized or locally advanced RCC following nephrectomy zur Studie |
Hampel C Roos F Thomas C Ziesel C |
| Avastin Avastin® first-line beim metastasiertem Nierenzellkarzinom |
Roos F |
| MARC2 An open label, single arm trial to characterize patients with metastatic renal cell carcinoma treated with everolimus after failure of the first VEGF-targeted therapy |
Roos F Frees S Thomas C Hampel C |
Studien bei Prostatakarzinom
| Projekt | Projektleiter |
|---|---|
| C21005 A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK 700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer that has Progressed During or Following Docetaxel-based Therapy |
Hampel C Frees S Roos F Thomas C |
Studien bei Blasenkarzinom
| Projekt | Projektleiter |
|---|---|
| JASIMA-JAVLOR Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract |
Hampel C Roos F Thomas C Frees S |
| TMX-101-001 A Phase I Dose Escalation Study of Intravesical TMX-101 in Subjects with Non-Muscle-Invasive Bladder Cancer zur Studie |
Hampel C Frees S Thomas C |
| OXN2503 An exploratory, randomised, double-blind, placebo-controlled, parallel group, pilot study to assess the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) compared to placebo in opioid-naïve Subjects suffering from severe pain due to Bladder Pain Syndrome (BPS). |
Hampel C Nestler S Wischnack M |
